From owner-chemistry@ccl.net Fri Sep 26 13:23:00 2025 From: "Wendy Anne Warr wendy]![warr.com" To: CCL Subject: CCL: Certainty Discovery Message-Id: <-55417-250926091326-24561-9hPHMW+QA8/i/01J/WeMKw/a\server.ccl.net> X-Original-From: "Wendy Anne Warr" Date: Fri, 26 Sep 2025 09:13:21 -0400 Sent to CCL by: "Wendy Anne Warr" [wendy+/-warr.com] Join me on November 4-5 in Frankfurt, Germany for the latest Certainty customer summit: Certainty Discovery. This two-day event demonstrates the combined expertise of Certara, Chemaxon, and their global community of customers, empowering scientists and research informaticians to achieve greater certainty in drug discovery. Day 1 features a scientific conference with renowned industry speakers discussing the impact of new modalities on therapy discovery. Day 2 focuses on practical solutions offered by Certara's discovery software suite, including D360, Certara AI, Design Hub, Compound Registration and Marvin. I had the pleasure of helping with the scientific program on Day 1. The outline program and details of speakers (Adrian Stevens, Nathan Brown, John G. Cumming, Claire Bellamy, Thomas Fox, Christian Baber, Mikls Fehr, Filip Miljkovi, and Matthias Gehringer) are at https://chemaxon.com/certainty- discovery. The day ends with drinks and a gala dinner. Free to attend but reserve your place now at https://chemaxon.com/certainty- discovery Dr. Wendy A. Warr Wendy Warr & Associates 6 Berwick Court, Holmes Chapel Cheshire, CW4 7HZ, England Tel. +44 (0)1477 533837 Cell: +44 (0)7957731937 wendy-$-warr.com http://orcid.org/0000-0002-7064-4739 https://www.warr.com Bluesky: -$-wendyannewarr.bsky.social